Literature DB >> 17475807

Sensorimotor gating in larval zebrafish.

Harold A Burgess1, Michael Granato.   

Abstract

Control of behavior in the natural environment where sensory stimuli are abundant requires superfluous information to be ignored. In part, this is achieved through selective transmission, or gating of signals to motor systems. A quantitative and clinically important measure of sensorimotor gating is prepulse inhibition (PPI) of the startle response, impairments in which have been demonstrated in several neuropsychiatric disorders, including schizophrenia. Here, we show for the first time that the acoustic startle response in zebrafish larvae is modulated by weak prepulses in a manner similar to mammalian PPI. We demonstrate that, like in mammals, antipsychotic drugs can suppress disruptions in zebrafish PPI induced by dopamine agonists. Because genetic factors underlying PPI are not well understood, we performed a screen and isolated mutant lines with reduced PPI. Analysis of Ophelia mutants demonstrates that they have normal sensory acuity and startle performance, but reduced PPI, suggesting that Ophelia is critical for central processing of sensory information. Thus, our results provide the first evidence for sensorimotor gating in larval zebrafish and report on the first unbiased screen to identify genes regulating this process.

Entities:  

Mesh:

Year:  2007        PMID: 17475807      PMCID: PMC6672105          DOI: 10.1523/JNEUROSCI.0615-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  189 in total

Review 1.  Comparability of behavioural assays using zebrafish larvae to assess neurotoxicity.

Authors:  J Legradi; N el Abdellaoui; M van Pomeren; J Legler
Journal:  Environ Sci Pollut Res Int       Date:  2014-11-18       Impact factor: 4.223

2.  The Behavioral and Pharmacological Actions of NMDA Receptor Antagonism are Conserved in Zebrafish Larvae.

Authors:  John Chen; Roshni Patel; Theodore C Friedman; Kevin S Jones
Journal:  Int J Comp Psychol       Date:  2010

3.  Using the zebrafish photomotor response for psychotropic drug screening.

Authors:  David Kokel; Randall T Peterson
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

4.  Neuromodulatory Regulation of Behavioral Individuality in Zebrafish.

Authors:  Carlos Pantoja; Adam Hoagland; Elizabeth C Carroll; Vasiliki Karalis; Alden Conner; Ehud Y Isacoff
Journal:  Neuron       Date:  2016-07-07       Impact factor: 17.173

5.  Pregnancy-Associated Plasma Protein-aa Regulates Photoreceptor Synaptic Development to Mediate Visually Guided Behavior.

Authors:  Andrew H Miller; Hollis B Howe; Bryan M Krause; Scott A Friedle; Matthew I Banks; Brian D Perkins; Marc A Wolman
Journal:  J Neurosci       Date:  2018-05-08       Impact factor: 6.167

6.  Mirror movement-like defects in startle behavior of zebrafish dcc mutants are caused by aberrant midline guidance of identified descending hindbrain neurons.

Authors:  Roshan A Jain; Hannah Bell; Amy Lim; Chi-Bin Chien; Michael Granato
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

7.  Neurobeachin is required postsynaptically for electrical and chemical synapse formation.

Authors:  Adam C Miller; Lisa H Voelker; Arish N Shah; Cecilia B Moens
Journal:  Curr Biol       Date:  2014-12-04       Impact factor: 10.834

8.  Presynaptic Inhibition Selectively Gates Auditory Transmission to the Brainstem Startle Circuit.

Authors:  Kathryn M Tabor; Trevor S Smith; Mary Brown; Sadie A Bergeron; Kevin L Briggman; Harold A Burgess
Journal:  Curr Biol       Date:  2018-08-02       Impact factor: 10.834

9.  Using zebrafish to assess the impact of drugs on neural development and function.

Authors:  Su Guo
Journal:  Expert Opin Drug Discov       Date:  2009-07-01       Impact factor: 6.098

10.  Temporal requirement for SMN in motoneuron development.

Authors:  Le T Hao; Phan Q Duy; James D Jontes; Marc Wolman; Michael Granato; Christine E Beattie
Journal:  Hum Mol Genet       Date:  2013-03-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.